Myogenica, Inc.
PrivateLast Round
Grant
Apr 1, 2024
Total Funding Raised
$600,000
Company Overview
Myogenica, Inc. is a biotechnology company that develops induced pluripotent stem cell-derived muscle stem cell therapies for the treatment of muscular dystrophy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myogenica, Inc. Comparables
Compare Myogenica, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyoPax | 83% | |
| Vita Therapeutics | 83% | |
| IPS HEART | 81% |
Myogenica, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2024 | ||||
| Seed | Mar 22, 2022 |
Myogenica, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Parent Project Muscular Dystrophy | Grant |
| Duchenne UK | Grant |
| SeedFolio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
$500K raised from Duchenne UK and Parent Project Muscular Dystrophy.
Myogenica, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Myogenica, Inc.'s valuation, stock price, and market status.
Is Myogenica, Inc. a public or private company?
Myogenica, Inc. is a private company.
What is the current stock price of Myogenica, Inc.?
Myogenica, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Myogenica, Inc. worth (valuation)?
Valuation information for Myogenica, Inc. is not publicly available.
Can I buy Myogenica, Inc. stock?
Myogenica, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Myogenica, Inc.'s last funding round?
Myogenica, Inc.'s most recent funding round was Grant on April 1, 2024.
Who are the main investors in Myogenica, Inc.?
Key investors in Myogenica, Inc. include Parent Project Muscular Dystrophy, Duchenne UK, SeedFolio.
Will Myogenica, Inc. IPO soon?
No public IPO plans have been announced for Myogenica, Inc..
How can I track Myogenica, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myogenica, Inc.'s secondary market activity and sign up for updates.